ApiJect Systems appoints James A. Garrett General Counsel and CCO
ApiJect Systems, a global injectable platform technology company that revolutionizes how medicines and vaccines are filled, finished, and delivered, announced that James A. Garrett (pictured) has joined the organization as its new General Counsel and Chief Compliance Officer. Mr. Garrett assumes responsibilities from Magdalena Fincham, who served as ApiJect’s counsel for Intellectual Property before stepping into the role of interim General Counsel.
Garrett joins ApiJect with extensive legal and strategic business expertise. Since 2012 he served in executive leadership roles at NuVasive, Inc., a global public company dedicated to advancing the adoption of less invasive surgery through procedural integration and the use of enabling technologies. As Senior Vice President for Business and Quality Systems, as well as Government & Regulations Strategy (2018-2020) he delivered strategic direction across multiple business units to support, among other things, the organization’s sterile packaging and device traceability solutions and quality management efforts.
He previously served NuVasive as Vice President, Chief Risk & Compliance Officer (2017-2019), and Vice President, Associate General Counsel (2012-2017). In these capacities, Mr. Garrett expanded risk management capabilities within the legal department, provided strategic management of global litigation, and actively led an extensive network of legal counsel, experts and advisors. From 2001-2010, Mr. Garrett practiced law across diverse industries including retail, manufacturing, and biological sciences/healthcare with the firms Brobeck Phleger & Harrison, (Associate, 2001-2003), Pillsbury Winthrop Shaw Pittman, (Senior Associate, 2003-2008), and DLA Piper, (Of Counsel, 2008–2010).